Trial Profile
Effects of Solifenacin or Mirabegron on Persistent Overactive Bladder Symptoms After Dutasteride Treatment in Patients With Benign Prostatic Hyperplasia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2015
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary) ; Solifenacin (Primary)
- Indications Benign prostatic hyperplasia; Overactive bladder
- Focus Therapeutic Use
- 02 Nov 2015 New trial record